Weight In Gold - Madison

Weight In Gold in Madison, Wisconsin operates as a physician-led obesity medicine practice under the direction of Dr. Leslie Golden, a board-certified MD credentialed by the American Board of Obesity Medicine. The clinic holds designation as an American Diabetes Association Certified Diabetes Center, reflecting its structured protocols for managing both obesity and metabolic disease within a single treatment framework. Dr. Golden's practice integrates pharmacotherapy, nutrition intervention, and behavioral modification rather than treating weight as an isolated metric, addressing the physiological drivers of obesity and type 2 diabetes through evidence-based protocols tailored to each patient's metabolic profile.

The clinic's pharmacotherapy program centers on three GLP-1 receptor agonists: liraglutide, semaglutide, and tirzepatide. Liraglutide is often introduced for patients requiring once-daily dosing or those with cardiovascular risk factors, given its FDA approval for reducing major adverse cardiac events. Semaglutide, available in both subcutaneous and oral formulations, is utilized for patients seeking once-weekly administration and demonstrated efficacy in clinical trials showing average weight reduction of 15-17% of body weight. Tirzepatide, a dual GIP/GLP-1 receptor agonist, is reserved for patients with obesity and comorbid type 2 diabetes or those who have not achieved target outcomes with single-agonist therapy. Dr. Golden titrates these medications based on tolerance, glycemic response, and weight trajectory, adjusting dosing schedules and combinations according to individual patient data rather than applying uniform protocols.

Dr. Leslie Golden completed her medical degree and residency training before pursuing additional certification in obesity medicine, a subspecialty requiring examination by the American Board of Obesity Medicine and ongoing CME in metabolic disease management. Her clinical approach treats obesity as a chronic disease with genetic, hormonal, and environmental components, rather than a lifestyle failure. Patients undergo comprehensive metabolic assessment including HbA1c, fasting insulin, lipid panels, and thyroid function before initiating GLP-1 therapy. The clinic's nutrition therapy component is delivered by registered dietitians who create individualized meal frameworks based on patients' cultural preferences, work schedules, and metabolic needs, rather than prescribing standardized calorie targets. Behavioral coaching addresses the psychological patterns surrounding food intake, stress eating, and long-term habit formation, with sessions structured to identify specific triggers and develop concrete coping strategies.

Patients at Weight In Gold begin with an initial consultation that includes a full medical history review, physical examination, and laboratory workup to assess candidacy for GLP-1 therapy and identify contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Follow-up visits occur every two to four weeks during the titration phase, then transition to monthly or quarterly monitoring once patients reach maintenance dosing. The clinic tracks not only weight and BMI but also waist circumference, blood pressure, fasting glucose, and patient-reported outcomes including energy levels, sleep quality, and medication side effects. Patients receive direct communication access to the clinical team for questions about dosing adjustments, managing gastrointestinal side effects, or navigating insurance prior authorization processes. The Madison clinic operates with both in-person appointments at its Wisconsin location and telehealth consultations for patients throughout Wisconsin, allowing continued care for patients who relocate within the state or prefer remote monitoring.

Weight In Gold differentiates itself through its dual certification in obesity medicine and diabetes care, enabling Dr. Golden to manage the full spectrum of metabolic disease without requiring patients to coordinate care across multiple specialists. The clinic does not promote rapid weight loss timelines or guarantee specific outcomes, instead emphasizing sustainable metabolic improvement and long-term disease management. Patients with type 2 diabetes often see reductions in HbA1c alongside weight loss, sometimes allowing for deprescribing of other glucose-lowering medications under physician supervision. The practice accepts insurance for medical visits and works with patients to navigate coverage for GLP-1 medications, which vary significantly by payer and plan type. For Wisconsin residents seeking physician-supervised obesity treatment with access to the latest incretin-based therapies, Weight In Gold provides a medically rigorous alternative to commercial weight loss programs, grounded in the pathophysiology of metabolic disease rather than caloric restriction alone.